Our trip to Orlando brings smart, actionable advice on preventing high and low blood sugars from diabetes guru and educator Mr. Gary Scheiner.
Conferences
Exciting and important news in the diabetes sphere from the biggest diabetes conferences around the world.
47 readers recommended
The 30th Annual Obesity Society Meeting brings exciting insights on drugs and mobile health.
113 readers recommended
Our trip to Berlin brought new insights on implantable GLP-1, the latest in CGM and the artificial pancreas, and debates on early insulin therapy.
30 readers recommended
The 2012 Diabetes Technology Meeting provides new insights into the artificial pancreas and the latest thinking on regulation from the FDA.
44 readers recommended
The artificial pancreas in peoples’ homes at the Annual Technologies & Treatments for Diabetes Meeting in Paris.
125 readers recommended
In late June, diaTribe sent our team to Chicago to attend the 67th Annual Scientific Sessions of the American Diabetes Association.
The American Association of Clinical Endocrinologists (AACE) 16th Annual Meeting & Clinical Congress
62 readers recommended
Main themes from AACE.
50 readers recommended
Can more type 2 therapies be used for type 1 diabetes?
41 readers recommended
The FDA impresses us at The Diabetes Mine Innovation Summit. Plus, sleek new software for downloading data to the cloud.
96 readers recommended
A game-changing therapy for type 2 diabetes? Plus, the latest on predictive low glucose suspend, faster insulin, and a better Bydureon.
37 readers recommended
What do Michelle Obama, soda, and cities have in common? Our top five patient takeaways from PHA this year.
49 readers recommended
Five key insights from April’s big-deal artificial pancreas meeting in Washington, DC.
27 readers recommended
The evolving field of type 1 diabetes and how research should improve to get closer to finding a cure.
23 readers recommended
What it felt like to forget about diabetes for a week.
79 readers recommended
At ADA this year, type 2 drugs for type 1 diabetes show lots of promise. Plus, the latest exciting data on the Medtronic Veo and hypoglycemia.
84 readers recommended
A whole new approach to treating type 2 diabetes at diagnosis, a new type of metformin, and the benefit of adding a GLP-1 agonist to insulin.
43 readers recommended
Even diabetes experts find management challenging. How to go online and to your providers for support.
24 readers recommended
Twitter summary: dT presents at @US_FDA on interim results for CVOT trials in #diabetes & why we can’t delay innovation In 2008, the FDA mandated that companies...
18 readers recommended
Will Medicare cover CGM? Will the FDA regulate meters? Experts meet in D.C. to discuss...
24 readers recommended
This year at ADA, the science was exciting as always, but what really made us happy was the deep focus on patient perspectives.